Literature DB >> 19266342

Aggregation chimeras: combining ES cells, diploid, and tetraploid embryos.

Mika Tanaka1, Anna-Katerina Hadjantonakis, Kristina Vintersten, Andras Nagy.   

Abstract

During the past 40 years, mouse chimeras have served as invaluable tools for studying not only genetics but also embryonic development, and the path from undifferentiated cell populations to fully committed functional cell types. This chapter gives a description of the early events of cell commitment and differentiation in the pre-and postimplantation-stage embryo. Next, a discussion follows highlighting the most commonly used as well as more recently developed applications of various cell types and origins used in the production of chimeras. Finally, detailed protocols and trouble-shooting suggestions will be presented for each of the steps involved.

Entities:  

Mesh:

Year:  2009        PMID: 19266342      PMCID: PMC2913464          DOI: 10.1007/978-1-59745-471-1_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Production of homozygous mutant ES cells with a single targeting construct.

Authors:  R M Mortensen; D A Conner; S Chao; A A Geisterfer-Lowrance; J G Seidman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Non-injection methods for the production of embryonic stem cell-embryo chimaeras.

Authors:  S A Wood; N D Allen; J Rossant; A Auerbach; A Nagy
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

3.  ES-cells carrying two inactivated myf-5 alleles form skeletal muscle cells: activation of an alternative myf-5-independent differentiation pathway.

Authors:  T Braun; H H Arnold
Journal:  Dev Biol       Date:  1994-07       Impact factor: 3.582

4.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

5.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

Authors:  G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Production of mice entirely derived from embryonic stem (ES) cell with many passages by coculture of ES cells with cytochalasin B induced tetraploid embryos.

Authors:  O Ueda; K Jishage; N Kamada; S Uchida; H Suzuki
Journal:  Exp Anim       Date:  1995-07

7.  Essential role of Mash-2 in extraembryonic development.

Authors:  F Guillemot; A Nagy; A Auerbach; J Rossant; A L Joyner
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Postimplantation development of tetraploid mouse embryos produced by electrofusion.

Authors:  M H Kaufman; S Webb
Journal:  Development       Date:  1990-12       Impact factor: 6.868

10.  Embryonic stem cells alone are able to support fetal development in the mouse.

Authors:  A Nagy; E Gócza; E M Diaz; V R Prideaux; E Iványi; M Markkula; J Rossant
Journal:  Development       Date:  1990-11       Impact factor: 6.868

View more
  11 in total

1.  Interordinal chimera formation between medaka and zebrafish for analyzing stem cell differentiation.

Authors:  Ni Hong; Songlin Chen; Ruowen Ge; Jianxing Song; Meisheng Yi; Yunhan Hong
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

2.  Twin Inc.

Authors:  Rose Hershenov; Derek Doroski
Journal:  Theor Med Bioeth       Date:  2018-08

3.  Accessibility of host cell lineages to medaka stem cells depends on genetic background and irradiation of recipient embryos.

Authors:  Ni Hong; Mingyou Li; Zhiqiang Zeng; Meisheng Yi; Jiaorong Deng; Jianfang Gui; Christoph Winkler; Manfred Schartl; Yunhan Hong
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

4.  Zfp281 is essential for epiblast maturation through a cell autonomous effect.

Authors:  Ruge Zang; Xin Huang; Dan Li; Hongwei Zhou; Shaorong Gao; Jianlong Wang
Journal:  J Genet Genomics       Date:  2021-09-17       Impact factor: 5.723

5.  KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.

Authors:  Laetitia Furio; Georgios Pampalakis; Iacovos P Michael; Andras Nagy; Georgia Sotiropoulou; Alain Hovnanian
Journal:  PLoS Genet       Date:  2015-09-21       Impact factor: 5.917

6.  Chimerism in piglets developed from aggregated cloned embryos.

Authors:  Yongye Huang; Zhanjun Li; Anfeng Wang; Xiaolei Han; Yuning Song; Lin Yuan; Tianye Li; Bing Wang; Liangxue Lai; Hongsheng Ouyang; Daxin Pang
Journal:  FEBS Open Bio       Date:  2016-03-15       Impact factor: 2.693

7.  Gene Expression Noise Enhances Robust Organization of the Early Mammalian Blastocyst.

Authors:  William R Holmes; Nabora Soledad Reyes de Mochel; Qixuan Wang; Huijing Du; Tao Peng; Michael Chiang; Olivier Cinquin; Ken Cho; Qing Nie
Journal:  PLoS Comput Biol       Date:  2017-01-23       Impact factor: 4.475

8.  Establishment of macaque trophoblast stem cell lines derived from cynomolgus monkey blastocysts.

Authors:  Shoma Matsumoto; Christopher J Porter; Naomi Ogasawara; Chizuru Iwatani; Hideaki Tsuchiya; Yasunari Seita; Yu-Wei Chang; Ikuhiro Okamoto; Mitinori Saitou; Masatsugu Ema; Theodore J Perkins; William L Stanford; Satoshi Tanaka
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

9.  Availability of empty zona pellucida for generating embryonic chimeras.

Authors:  Chi-Hun Park; Young-Hee Jeong; Dong-Kyung Lee; Jae Yeon Hwang; Kyung-Jun Uh; Su-Cheong Yeom; Curie Ahn; Chang-Kyu Lee
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells.

Authors:  Tiong-Ti Lim; Caroline Geisen; Michael Hesse; Bernd K Fleischmann; Katrin Zimmermann; Alexander Pfeifer
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.